Here's What the Street Thinks About Addus HomeCare (ADUS)
Addus HomeCare Corporation (NASDAQ:ADUS) is one of the Overlooked Small Cap Stocks to Buy Now. Wall Street has a positive opinion on Addus HomeCare Corporation (NASDAQ:ADUS) ahead of its fiscal Q4 2025 earnings, expected to be released on February 24, 2026. Analysts expect the company to post roughly $372.87 million in revenue, along with a GAAP EPS of $1.56.
On January 7, Clarke Murphy from Truist Financial initiated Addus HomeCare Corporation (NASDAQ:ADUS) with a Buy rating and a $135 price target. Earlier on December 10, Joanna Gajuk from Bank of America Securities also reiterated a Buy rating on the stock with a $147 price target.
Analysts at BofA noted that the positive rating is based on multiple growth drivers supporting the company’s outlook. The firm highlighted that Addus is expected to benefit from rate increases in Texas, which supports management’s mid-to-high single-digit organic growth target for Personal Care. Moreover, BofA also likes the company’s hiring momentum which is expected to increase turnover rates. The firm highlighted that Addus’s strategic focus on Personal Care acquisitions positions it for future expansion.
Addus HomeCare Corporation (NASDAQ:ADUS) provides in-home care services across three main segments including Personal Care, Hospice, and Home Health.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Western Union to launch stablecoin next month, with 'Stable Card' planned for global consumers
US Dollar Index declines below 98.50 as Iran offers US deal to reopen Strait of Hormuz
TRUMP loses key support after $161M wipeout – Is a recovery to $3 possible?

Crypto Startups See Strong Week with $53.6M Raised
